B.C. penny stock company from Bridgemark case sues lawyer

  • 📰 BurnabyNOW_News
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 77%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

PreveCeutical Medical is blaming its former lawyer for writing a press release that was found to be misleading by a hearing panel at the B.C. Securities Commission; the company was cleared of allegations it breached the Securities Act.

A company that once claimed it was developing technology based on scorpion venom has filed a civil claim against the firm’s former lawyer, claiming he is responsible for a controversial press release found to have contained misrepresentations.

The B.C. Securities Commission dropped its allegations against most of the group but ultimately alleged Preveceutical made misrepresentations in a news release. However, a panel of adjudicators ruled on May 2 that the news release was only misleading and not a misrepresentation in a legal sense, as it did not have a material impact on investors.

“As a result of the defendants’ breach of the standard of care, the plaintiffs have suffered various damages due to, among other things, their exposure to regulatory proceedings arising from the Notice of Hearing and the finding of the British Columbia Securities Commission that the news release and the material change report contained misrepresentations,” the claim states.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 14. in BE
 

Merci pour votre commentaire. Votre commentaire sera publié après examen.

Belgique Dernières Nouvelles, Belgique Actualités